Nanobiotix ADR [NASDAQ: NBTX] loss -4.00% on the last trading session, reaching $20.38 price per share at the time.
Nanobiotix ADR represents 48.21 million in outstanding shares, while the company has a total market value of $976.61 million with the latest information. NBTX stock price has been found in the range of $19.14 to $20.54.
If compared to the average trading volume of 93.44K shares, NBTX reached a trading volume of 158611 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Nanobiotix ADR [NBTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NBTX shares is $20.05 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NBTX stock is a recommendation set at 1.22. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Nanobiotix ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 28, 2024. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on December 08, 2023, representing the official price target for Nanobiotix ADR stock.
Trading performance analysis for NBTX stock
Nanobiotix ADR [NBTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.91. With this latest performance, NBTX shares gained by 15.60% in over the last four-week period, additionally plugging by 407.42% over the last 6 months – not to mention a rise of 610.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NBTX stock in for the last two-week period is set at 49.13, with the RSI for the last a single of trading hit 1.68, and the three-weeks RSI is set at 1.93 for Nanobiotix ADR [NBTX]. The present Moving Average for the last 50 days of trading for this stock 20.56, while it was recorded at 20.98 for the last single week of trading, and 8.96 for the last 200 days.
Nanobiotix ADR (NBTX) Capital Structure & Debt Analysis
Nanobiotix ADR (NBTX) Efficiency & Liquidity Metrics
Nanobiotix ADR (NBTX) Efficiency & Liquidity Metrics
Nanobiotix ADR [NBTX]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NBTX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Nanobiotix ADR go to 36.01%.
An analysis of Institutional ownership at Nanobiotix ADR [NBTX]
There are presently around $11.71%, or 11.71%% of NBTX stock, in the hands of institutional investors. The top three institutional holders of NBTX stocks are: JOHNSON & JOHNSON with ownership of 5.62 million shares, which is approximately 15.2291%. BAILLIE GIFFORD & CO, holding 2.87 million shares of the stock with an approximate value of $$14.35 million in NBTX stocks shares; and BAILLIE GIFFORD & CO, currently with $$2.78 million in NBTX stock with ownership which is approximately 1.5031%.
